Through the Anthony Nolan Cell & Gene Therapy Service’s provision of cellular material to cell and gene therapy researchers, we are familiar with industry standards and clients’ requirements. But we wanted to find out more about what drives decision making when selecting a cell source provider, and set out the key questions you should be…

Read more >

Cell and gene therapies have the potential to be transformative for patients. With the right support, researchers and developers have an opportunity to become leaders in this competitive global market. The number of allogeneic cell-based therapies in development is greater than ever, but how can organisations ensure they have a sustainable supply of starting material?…

Read more >